ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $74,000 | -46.4% | 2,882 | +11.5% | 0.00% | -66.7% |
| Q4 2020 | $138,000 | +46.8% | 2,584 | +12.8% | 0.00% | +50.0% |
| Q3 2020 | $94,000 | -74.2% | 2,290 | -87.0% | 0.00% | -85.7% |
| Q3 2018 | $365,000 | +314.8% | 17,604 | +500.4% | 0.01% | +133.3% |
| Q4 2017 | $88,000 | -87.0% | 2,932 | -83.6% | 0.01% | -90.0% |
| Q3 2017 | $675,000 | +58.1% | 17,928 | +17.1% | 0.06% | +42.9% |
| Q2 2017 | $427,000 | -9.1% | 15,310 | +12.0% | 0.04% | -27.6% |
| Q1 2017 | $470,000 | +45.5% | 13,674 | +22.2% | 0.06% | +26.1% |
| Q4 2016 | $323,000 | -5.0% | 11,194 | +4.7% | 0.05% | -11.5% |
| Q3 2016 | $340,000 | – | 10,696 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |